PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Spanish officials yank Novocat’s GMP certification after inspectors turn up serious shortfalls

Barcelona-based generic drug manufacturer Novocat Farma was cited by Spanish regulators for a number of manufacturing noncompliance issues following an inspection e...
Continue Reading →
News

White House backs importing drugs from abroad

(Credit: Depositphotos ) The Trump administration on Wednesday proposed allowing the importation of lower-priced drugs from foreign countries in its latest bid t...
Continue Reading →
News

Congress is going after drug prices. Pharma CEOs aren’t panicking, yet

(Credit: Brian Tucker / BioPharma Dive ) In the Senate, lawmakers have proposed legislation that would penalize drugmakers hiking the prices of their products ab...
Continue Reading →
News

Pentagon eyeing Chinese production of tainted ‘sartan’ API as trade war grows

The Pentagon is scrutinizing Chinese-made API in "sartan" drugs as a possible health threat. (Getty) A series of FDA recalls on “sartan” active ingredients made ...
Continue Reading →
News

A $10B settlement? Or $45B? Distributors, AGs go back and forth in opioid talks: Bloomberg

Distributors have pitched a $10 billion opioid settlement with state attorneys general, Bloomberg reports. (SARINYAPINNGAM/iStock/Getty Images Plus) In the compl...
Continue Reading →
News

CPhI MEA expert: ‘growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East’

Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region. Abu Dhab...
Continue Reading →
News

Drive for generics sees Korea increasingly attractive to international pharma

CPhI Korea data shows an increase in ‘overall competitiveness’ Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Kor...
Continue Reading →
News

Amgen sales slide as copies dig into Sensipar, Neulasta

Amgen's CGRP launch Aimovig generated $83 million during the second quarter, helping offset losses of exclusivity that cost the drugmaker. (Amgen) Amgen is conte...
Continue Reading →
News

How Mylan ended as a junior partner in its Pfizer deal

(Credit: Getty ) As the biopharma bull market reached its peak in 2015, a three-way acquisition battle raged across the generics sector, with Mylan cha...
Continue Reading →
News

Leading oncologists and nutritionists pinpoint areas to catalyze nutrition-based cancer prevention

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026